Redox Pharmaceutical Corporation announced the granting of a new United States patent on the use of CTC-96 (Doxovir™) for the Treatment of Psoriasis.

Redox Pharmaceutical Corporation has successfully completed Phase IB and Phase II Clinical Trials for Herpes Labialis (cold sores).

We encourage you to contact us if you have any questions or would like additional information about Redox Pharmaceutical Corporation. Our corporate offices are located at:

Redox Pharmaceutical Corporation
100 Forest Drive
Greenvale, NY 11548
Tel: 516.484.0864
Email: cblecher@redoxpharm.com